14675-48-0

14675-48-0 structure

Name: 9H-Purine, 6-methyl-9-b-D-ribofuranosyl
Chemical Name: 6-methylpurine riboside
CAS Number: 14675-48-0
Molecular Formula: C₁₁H₁₄N₄O₄
Molecular Weight: 266.25
Catalog: Signaling Pathways Cell Cycle/DNA Damage Nucleoside Antimetabolite/Analog
Create Date: 2018-12-29 18:05:33
Modify Date: 2026-08-15 07:47:42
6-Methylpurine riboside is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

Name	6-methylpurine riboside
Synonyms	6-D-MPR (2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-methyl-9H-purin-9-yl)tetrahydrofuran-3,4-diol 6-Methyl-9-(beta-D-ribofuranosyl)-9H-purine 6-Methylpurine-β-D-riboside 6-Methylpurine ribonucleoside Nsc101619 6-Methylpurine-beta-D-riboside 6-methylpurine-riboside (2r,3s,4r,5r)-2-(hydroxymethyl)-5-(6-methyl-1H-purin-9-yl)tetrahydrofuran-3,4-diol 6-Methyl-9-(1-β-D-ribofuranosyl)purine 6-Methyl-9-(beta-D-ribofuranosyl)-9H-purine, natural antibiotics, antifungal antiviral agent 6-METHYLPURINE RIBOSIDE 6-methyl-9-β-D-ribofuranosyl-9H-purine 9H-Purine, 6-methyl-9-.beta.-D-ribofuranosyl (2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-methyl-9H-purin-9-yl)oxolane-3,4-diol 9H-Purine, 6-methyl-9-β-D-ribofuranosyl 6-Methyl-9.beta.-D-ribofuranosylpurine 6-Methylpurine-9-beta-D-ribofuranoside (2R,3S,4R,5R)-2-(HydroxyMethyl)-5-(6-Methyl-9H-purin-9-yl)tetrahydrofuran-3,4-diol 6-METHYLPURINE

Description	6-Methylpurine riboside is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Related Catalog	Signaling Pathways >> Cell Cycle/DNA Damage >> Nucleoside Antimetabolite/Analog Research Areas >> Others
References	[1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.